We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$658M
AUM Growth
+$538M
(+447%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
83.75%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
4
Increased
–
Reduced
3
Closed
–
Top Buys
| 1 |
ALX Oncology
ALXO
|
+$381M |
| 2 |
Harmony Biosciences
HRMY
|
+$128M |
| 3 |
CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
|
+$47.1M |
| 4 |
MTCR
Metacrine, Inc. Common Stock
MTCR
|
+$31.3M |
Top Sells
| 1 |
AKRO
Akero Therapeutics
AKRO
|
+$24.7M |
| 2 |
Precision BioSciences
DTIL
|
+$9.9M |
| 3 |
VRNA
Verona Pharma
VRNA
|
+$1.78M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ALX Oncology
ALXO
$265M
| $366M | 55.63% |
+9,699,925
| New | +$381M |
|
|
2
Harmony Biosciences
HRMY
$1.89B
| $119M | 18.06% |
+3,504,624
| New | +$128M |
|
|
AKRO
3
DELISTED
Akero Therapeutics
AKRO
| $75.3M | 11.44% |
2,444,311
-705,708
| -22% | -$24.7M |
|
|
CMPI
4
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $42.3M | 6.43% |
+3,673,374
| New | +$47.1M |
|
|
MTCR
5
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $31.2M | 4.75% |
+3,059,123
| New | +$31.3M |
|
|
APLS
6
DELISTED
Apellis Pharmaceuticals
APLS
| $15.1M | 2.3% |
501,584
| – | – |
|
|
7
Precision BioSciences
DTIL
$227M
| $8M | 1.22% |
43,273
-49,780
| -53% | -$9.9M |
|
|
VRNA
8
DELISTED
Verona Pharma
VRNA
| $1.24M | 0.19% |
199,075
-257,695
| -56% | -$1.78M |
|
Similar funds
OCWP
FFP
BDA
PHC
SA
ACC
NRCM
IP